John Stephen Healy - 30 Jan 2026 Form 4 Insider Report for Contineum Therapeutics, Inc. (CTNM)

Role
General Counsel and Corp Sec
Signature
/s/ Peter Slover, Attorney-in-Fact
Issuer symbol
CTNM
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
30 Jan 2026, 16:59:54 UTC
Previous filing
31 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Healy John Stephen General Counsel and Corp Sec 3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO /s/ Peter Slover, Attorney-in-Fact 30 Jan 2026 0001908071

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTNM Stock Option (right to buy) Award $0 +206,411 $0.000000 206,411 30 Jan 2026 Class A Common Stock 206,411 $14.26 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.